A detailed history of Bridgeway Capital Management, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 140,000 shares of FULC stock, worth $516,600. This represents 0.02% of its overall portfolio holdings.

Number of Shares
140,000
Holding current value
$516,600
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$2.97 - $4.84 $415,800 - $677,600
140,000 New
140,000 $658,000
Q1 2024

May 15, 2024

SELL
$6.7 - $12.0 $254,171 - $455,232
-37,936 Reduced 29.99%
88,564 $836,000
Q2 2023

Aug 14, 2023

BUY
$2.26 - $3.8 $285,890 - $480,700
126,500 New
126,500 $417,000
Q4 2022

Feb 14, 2023

SELL
$5.01 - $8.35 $175,350 - $292,250
-35,000 Reduced 46.67%
40,000 $291,000
Q3 2022

Nov 14, 2022

BUY
$4.92 - $9.1 $369,000 - $682,500
75,000 New
75,000 $607,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $192M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.